Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOTEGRAVIR Cause Viral mutation identified? 169 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 169 reports of Viral mutation identified have been filed in association with CABOTEGRAVIR (Apretude). This represents 2.0% of all adverse event reports for CABOTEGRAVIR.

169
Reports of Viral mutation identified with CABOTEGRAVIR
2.0%
of all CABOTEGRAVIR reports
0
Deaths
9
Hospitalizations

How Dangerous Is Viral mutation identified From CABOTEGRAVIR?

Of the 169 reports, 9 (5.3%) required hospitalization, and 1 (0.6%) were considered life-threatening.

Is Viral mutation identified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 169 reports have been filed with the FAERS database.

What Other Side Effects Does CABOTEGRAVIR Cause?

Product dose omission issue (1,121) Off label use (1,049) Injection site pain (924) Viral load increased (452) Pain (399) Virologic failure (275) Pathogen resistance (270) Pyrexia (255) Product use in unapproved therapeutic environment (234) Inappropriate schedule of product administration (228)

What Other Drugs Cause Viral mutation identified?

LAMIVUDINE (1,631) TENOFOVIR DISOPROXIL (730) EFAVIRENZ (641) ZIDOVUDINE (531) NEVIRAPINE (518) DOLUTEGRAVIR (510) ABACAVIR (378) RALTEGRAVIR (284) STAVUDINE (258) RITONAVIR (228)

Which CABOTEGRAVIR Alternatives Have Lower Viral mutation identified Risk?

CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE CABOTEGRAVIR vs CABOZANTINIB CABOTEGRAVIR vs CABOZANTINIB S-MALATE CABOTEGRAVIR vs CAFFEINE CABOTEGRAVIR vs CALASPARGASE PEGOL

Related Pages

CABOTEGRAVIR Full Profile All Viral mutation identified Reports All Drugs Causing Viral mutation identified CABOTEGRAVIR Demographics